Work

Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.4162.4162

Authors: David L. Porter, Michael Kalos, Noelle V. Frey, Stephan A. Grupp, Alison W. Loren, Christina Jemison, Joan Gilmore, Holly McConville, James Capobianchi, Lester Lledo, Anne Chew, Zhaohui Zheng, Bruce L. Levine, Carl H. June

Institutions: Abramson Cancer Center, University of Pennsylvania, Children's Hospital of Philadelphia

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979691690

FWCI: 3.328

Cites:

Cited by: 29

Related to: 10